These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 16056257)

  • 1. Immune responses to tuberculosis in developing countries: implications for new vaccines.
    Rook GA; Dheda K; Zumla A
    Nat Rev Immunol; 2005 Aug; 5(8):661-7. PubMed ID: 16056257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune systems in developed and developing countries; implications for the design of vaccines that will work where BCG does not.
    Rook GA; Dheda K; Zumla A
    Tuberculosis (Edinb); 2006; 86(3-4):152-62. PubMed ID: 16510309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
    Changhong S; Hai Z; Limei W; Jiaze A; Li X; Tingfen Z; Zhikai X; Yong Z
    Tuberculosis (Edinb); 2009 Jan; 89(1):54-61. PubMed ID: 19056317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do successful tuberculosis vaccines need to be immunoregulatory rather than merely Th1-boosting?
    Rook GA; Dheda K; Zumla A
    Vaccine; 2005 Mar; 23(17-18):2115-20. PubMed ID: 15755581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of recombinant bacille Calmette-Guérin vaccine secreting interleukin-15/antigen 85B fusion protein in providing protection against Mycobacterium tuberculosis.
    Tang C; Yamada H; Shibata K; Maeda N; Yoshida S; Wajjwalku W; Ohara N; Yamada T; Kinoshita T; Yoshikai Y
    J Infect Dis; 2008 May; 197(9):1263-74. PubMed ID: 18422438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced immunoprotective potential of Mycobacterium tuberculosis Ag85 complex protein based vaccine against airway Mycobacterium tuberculosis challenge following intranasal administration.
    Giri PK; Verma I; Khuller GK
    FEMS Immunol Med Microbiol; 2006 Jul; 47(2):233-41. PubMed ID: 16831210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An attenuated Salmonella-vectored vaccine elicits protective immunity against Mycobacterium tuberculosis.
    Wang QL; Pan Q; Ma Y; Wang K; Sun P; Liu S; Zhang XL
    Vaccine; 2009 Nov; 27(48):6712-22. PubMed ID: 19733584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel DNA vaccine containing multiple TB-specific epitopes cast in a natural structure elicits enhanced Th1 immunity compared with BCG.
    Gao H; Li K; Yu S; Xiong S
    Microbiol Immunol; 2009 Oct; 53(10):541-9. PubMed ID: 19780967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of mutant mycobacteria as new vaccines to prevent tuberculosis.
    Hernàndez Pando R; Aguilar LD; Infante E; Cataldi A; Bigi F; Martin C; Gicquel B
    Tuberculosis (Edinb); 2006; 86(3-4):203-10. PubMed ID: 16542875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells.
    Lindenstrøm T; Agger EM; Korsholm KS; Darrah PA; Aagaard C; Seder RA; Rosenkrands I; Andersen P
    J Immunol; 2009 Jun; 182(12):8047-55. PubMed ID: 19494330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasmid encoding human IL-12 improve protective efficacy of Mtb8.4 gene vaccine with signal sequence against infection of Mycobacterium Tuberculosis].
    Li H; Li R; Zhong S; Ren H
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Apr; 23(4):291-4. PubMed ID: 17428378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection.
    Wozniak TM; Ryan AA; Triccas JA; Britton WJ
    Infect Immun; 2006 Jan; 74(1):557-65. PubMed ID: 16369012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Th1 cell reactivity and HLA-DR binding prediction for promiscuous recognition of MPT63 (Rv1926c), a major secreted protein of Mycobacterium tuberculosis.
    Mustafa AS
    Scand J Immunol; 2009 Mar; 69(3):213-22. PubMed ID: 19281533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Half-truths and selective memory: Interferon gamma, CD4(+) T cells and protective memory against tuberculosis.
    Goldsack L; Kirman JR
    Tuberculosis (Edinb); 2007 Nov; 87(6):465-73. PubMed ID: 17719276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant DNA vaccine of the early secreted antigen ESAT-6 by Mycobacterium tuberculosis and Flt3 ligand enhanced the cell-mediated immunity in mice.
    Xu J; Xu W; Chen X; Zhao D; Wang Y
    Vaccine; 2008 Aug; 26(35):4519-25. PubMed ID: 18598729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and protective efficacy of a DNA vaccine encoding the fusion protein of mycobacterium heat shock protein 65 (Hsp65) with human interleukin-2 against Mycobacterium tuberculosis in BALB/c mice.
    Wang LM; Bai YL; Shi CH; Gao H; Xue Y; Jiang H; Xu ZK
    APMIS; 2008 Dec; 116(12):1071-81. PubMed ID: 19133010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudo-rationale design of efficient TB vaccines: lesson from the mycobacterial 27-kDa lipoprotein.
    Hovav AH; Bercovier H
    Tuberculosis (Edinb); 2006; 86(3-4):225-35. PubMed ID: 16515885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New alternative vaccine component against mycobacterium tuberculosis--heat shock protein 16.3 or its T-cell epitope.
    Shi C; Zhang H; Zhang T; Wang X; Bai B; Zhao Y; Zhang C; Xu Z
    Scand J Immunol; 2009 Nov; 70(5):465-74. PubMed ID: 19874551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
    Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
    Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.